Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis

Title
Phase II Study of Dasatinib in Philadelphia Chromosome-Negative Acute and Chronic Myeloid Diseases, Including Systemic Mastocytosis
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 14, Issue 12, Pages 3906-3915
Publisher
American Association for Cancer Research (AACR)
Online
2008-06-17
DOI
10.1158/1078-0432.ccr-08-0366

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started